We are live on ! Find out more
HCM

Hoplite Capital Management Portfolio holdings

AUM $15.1M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
-27.41%
3 Year Est. Return
+32.9%
5 Year Est. Return
+85.27%
10 Year Est. Return
–
AUM
$1.98B
AUM Growth
-$324M
Cap. Flow
-$309M
Cap. Flow %
-15.58%
Top 10 Hldgs %
67.5%
Holding
36
New
10
Increased
4
Reduced
10
Closed
9

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$135M
2
AVGO icon
Broadcom
AVGO
+$43M
3
MNST icon
Monster Beverage
MNST
+$37.1M
4
UNH icon
UnitedHealth
UNH
+$25.9M
5
DATA
Tableau Software, Inc.
DATA
+$25.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$121M
2
ABBV icon
AbbVie
ABBV
+$93.2M
3
AGN
Allergan plc
AGN
+$89.7M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$77.5M
5
ADSK icon
Autodesk
ADSK
+$60.5M

Sector Composition

Rank Sector Weight
1 Communication Services 26.62%
2 Consumer Discretionary 24.66%
3 Healthcare 13.76%
4 Consumer Staples 9.32%
5 Technology 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CFG icon
26
Citizens Financial Group
CFG
$30.5B
$12.9M 0.65%
+616,290
New +$13.1M
BRK.A icon
27
Berkshire Hathaway Class A
BRK.A
$1.13T
$427K 0.02%
2
– –
ABBV icon
28
AbbVie
ABBV
$431B
– –
-1,573,047
Closed -$93.2M
ADSK icon
29
Autodesk
ADSK
$50.9B
– –
-993,450
Closed -$60.5M
BAC icon
30
Bank of America
BAC
$439B
– –
-1,721,849
Closed -$29M
GPRO icon
31
GoPro
GPRO
$125M
– –
-1,087,148
Closed -$19.6M
JAZZ icon
32
Jazz Pharmaceuticals
JAZZ
$16.7B
– –
-551,310
Closed -$77.5M
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$123B
– –
-961,531
Closed -$121M
WCN
34
Waste Connections
WCN
$42.1B
– –
-1,591,077
Closed -$59.7M
QUNR
35
DELISTED
Qunar Cayman Islands Limited
QUNR
– –
-716,641
Closed -$37.8M
QLIK
36
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
– –
-1,190,552
Closed -$37.7M
1
2

Similar funds

PCP
Prisma Capital Partners New York $17.5M AUM 42.28% 1-Year Est. Return
DCM
Dynamic Capital Management St. Helier, Jersey $12M AUM 0.65% 1-Year Est. Return
FCM
Force Capital Management New York $11.4M AUM 5.65% 1-Year Est. Return
RGNCM
R.G. Niederhoffer Capital Management New York $11.3M AUM
ICP
IBIS Capital Partners London, United Kingdom $19.4M AUM 0.49% 1-Year Est. Return
PVAM
Pacific View Asset Management San Francisco, California $20.8M AUM 20.08% 1-Year Est. Return
CIM
Consilium Investment Management Ft. Lauderdale, Florida $21M AUM 29.5% 1-Year Est. Return
LAM
Lyxor Asset Management New York $8.58M AUM 3.07% 1-Year Est. Return

Hoplite Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Hoplite Capital Management held 36 positions worth $1.98B, down 14% from $2.31B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Hoplite Capital Management withdrew a net $309M in Q1 2016, closing 9 positions and reducing 10 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 27% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Hoplite Capital Management opened a new position in Meta Platforms (Facebook) worth $146M.

  • Hoplite Capital Management's largest Q1 2016 buy was Meta Platforms (Facebook): 1,275,684 shares worth $146M.
  • Hoplite Capital Management added most to LyondellBasell Industries in Q1 2016, an estimated $20.4M increase.
  • Hoplite Capital Management's biggest Q1 2016 reduction was Allergan plc, cutting an estimated $89.7M.
  • Hoplite Capital Management fully exited Vertex Pharmaceuticals in Q1 2016, selling an estimated $121M.
  • Hoplite Capital Management's ten largest holdings make up 67% of its $1.98B portfolio in Q1 2016.
  • Hoplite Capital Management opened 10 new positions and closed 9 in Q1 2016.
  • Hoplite Capital Management's portfolio value fell 14% quarter-over-quarter to $1.98B.

Based on Hoplite Capital Management's 13F filing for Q1 2016, filed 16 May 2016.